Quick Order Cart

Cat. No. ARG43875

Gdf1 Knockout Hepa 1-6 Cell Line

  • Product Type:

    In Stock Cell Lines

  • Species:

    Mus musculus (Mouse)

  • Tissue Source:

    Liver

  • Disease:

    Hepatocellular carcinoma

The Gdf1 Knockout Hepa 1-6 Cell Line is a CRISPR/Cas9-edited knockout cell line generated from mouse Hepa 1-6 hepatoma cells. This model disrupts the Gdf1 gene, encoding Growth Differentiation Factor 1 (GDF1), a TGF-beta superfamily ligand essential for left-right axis determination and SMAD2/3 signaling via ALK4/ActRIIB receptor complexes. With endogenous GDF1 eliminated, this cell line enables precise investigation of GDF1-dependent pathways, including SMAD2/3 phosphorylation and Pitx2 induction, in a hepatocellular context. It is ideal for studies of TGF-beta signaling, left-right determination, and hepatocyte-specific signal transduction using assays such as Western blot and luciferase reporters.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Hepa 1-6

    Gene Name

    Gdf1

    Gene Identifier

    NCBI Gene ID 14559

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The Gdf1 Knockout Hepa 1-6 Cell Line is a CRISPR/Cas9-edited knockout cell line generated from the mouse Hepa 1-6 hepatoma line. This product features targeted disruption of the Gdf1 gene, which encodes Growth Differentiation Factor 1 (GDF1), a TGF-beta superfamily ligand critical for left-right axis determination. The knockout provides a stable loss-of-function model for studying GDF1-dependent signaling, enabling dissection of its role in cellular processes.

The host Hepa 1-6 cell line is a mouse hepatoma derived from the C57L strain, retaining key characteristics of liver parenchymal cells including metabolic and detoxification functions. This hepatic origin offers a physiologically relevant system for investigating TGF-beta superfamily signaling in the context of hepatocyte biology, liver metabolism, and hepatocellular carcinoma research.

GDF1 functions as a secreted ligand that assembles receptor complexes of ALK4 and ActRIIB, with the co-receptor Cripto. Ligand binding induces phosphorylation of SMAD2 and SMAD3, which upon SMAD4 binding, translocate to the nucleus to regulate target genes such as Pitx2. Upstream, Gdf1 expression is controlled by Nodal and FoxH1. Knockout of Gdf1 eliminates this signaling axis, blocking SMAD2/3 activation and downstream transcriptional events.

In the hepatocellular context of Hepa 1-6 cells, the Gdf1 knockout allows exploration of TGF-beta superfamily signaling beyond embryonic left-right determination. Although GDF1 is primarily associated with developmental patterning, TGF-beta pathways play important roles in liver physiology, fibrosis, and cancer. This cell line enables distinction of GDF1-specific effects from those of related ligands, shedding light on its potential non-developmental functions in hepatocyte signaling.

Researchers can employ this knockout cell line for diverse functional studies, including analysis of SMAD2/3 phosphorylation by Western blot, measurement of Pitx2 expression via RT-qPCR, and assessment of pathway activity using SMAD-responsive luciferase reporters. Co-immunoprecipitation can probe receptor-ligand interactions. The Gdf1 Knockout Hepa 1-6 Cell Line is an essential tool for dissecting TGF-beta signaling, left-right determination, and hepatocyte signal transduction. Please contact Ascent Research for further information.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)